Johannes Wiegand

7.9k total citations
132 papers, 2.6k citations indexed

About

Johannes Wiegand is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Johannes Wiegand has authored 132 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Epidemiology, 94 papers in Hepatology and 13 papers in Infectious Diseases. Recurrent topics in Johannes Wiegand's work include Hepatitis C virus research (78 papers), Liver Disease Diagnosis and Treatment (74 papers) and Hepatitis B Virus Studies (57 papers). Johannes Wiegand is often cited by papers focused on Hepatitis C virus research (78 papers), Liver Disease Diagnosis and Treatment (74 papers) and Hepatitis B Virus Studies (57 papers). Johannes Wiegand collaborates with scholars based in Germany, United States and France. Johannes Wiegand's co-authors include Thomas Berg, Heiner Wedemeyer, Hans L. Tillmann, Thomas Karlas, Michael P. Manns, Markus Cornberg, Joachim Mössner, Volker Keim, David Petroff and T. Santantonio and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Johannes Wiegand

128 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes Wiegand Germany 29 1.9k 1.8k 323 271 255 132 2.6k
Yoav Lurie Israel 25 1.5k 0.8× 1.3k 0.7× 141 0.4× 220 0.8× 282 1.1× 84 2.4k
Mark Wright United Kingdom 26 1.2k 0.6× 1.1k 0.6× 223 0.7× 114 0.4× 236 0.9× 81 2.1k
John Koskinas Greece 32 2.0k 1.0× 2.1k 1.2× 223 0.7× 232 0.9× 467 1.8× 140 3.5k
Norio Horiike Japan 35 2.2k 1.1× 2.2k 1.2× 896 2.8× 300 1.1× 326 1.3× 166 3.8k
Massimo Colombo Italy 29 3.2k 1.7× 3.2k 1.8× 117 0.4× 452 1.7× 265 1.0× 98 4.1k
Chung‐Feng Huang Taiwan 28 2.3k 1.2× 2.3k 1.3× 158 0.5× 171 0.6× 128 0.5× 204 3.2k
M.P. Manns Germany 24 937 0.5× 970 0.5× 256 0.8× 148 0.5× 214 0.8× 131 2.0k
Masaru Enomoto Japan 27 1.6k 0.8× 1.6k 0.9× 104 0.3× 160 0.6× 236 0.9× 165 2.6k
Ramazan Idılman Türkiye 32 3.1k 1.6× 2.8k 1.6× 90 0.3× 218 0.8× 469 1.8× 176 4.0k
Holger Hinrichsen Germany 24 2.1k 1.1× 2.3k 1.3× 148 0.5× 398 1.5× 112 0.4× 111 2.9k

Countries citing papers authored by Johannes Wiegand

Since Specialization
Citations

This map shows the geographic impact of Johannes Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Wiegand more than expected).

Fields of papers citing papers by Johannes Wiegand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Wiegand. The network helps show where Johannes Wiegand may publish in the future.

Co-authorship network of co-authors of Johannes Wiegand

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Wiegand. A scholar is included among the top collaborators of Johannes Wiegand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Wiegand. Johannes Wiegand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petroff, David, Jörn M. Schattenberg, S Zeuzem, et al.. (2025). Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry. Zeitschrift für Gastroenterologie. 63(8). 836–843. 1 indexed citations
2.
Bantel, Heike, Peter Buggisch, Andreas Geier, et al.. (2025). Metabolic Dysfunction–Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel. Liver International. 45(8). e70225–e70225. 3 indexed citations
3.
Trawinski, Henning, et al.. (2024). Alveolar Echinococcosis – Diagnostic challenges of a parasitic disease on the rise in Europe – a case report. Zeitschrift für Gastroenterologie. 63(1). 49–52. 1 indexed citations
4.
Bätz, Olaf, et al.. (2024). Successful hepatitis B and C screening in the health check-up in the German primary care setting. JHEP Reports. 6(9). 101122–101122. 2 indexed citations
5.
Blank, Valentin, et al.. (2024). Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis. PLoS ONE. 19(5). e0304026–e0304026. 1 indexed citations
6.
Blank, Valentin, Thomas Karlas, Ulf Anderegg, et al.. (2024). Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease. Liver International. 44(8). 2075–2090. 1 indexed citations
7.
Horvatits, Thomas, Patrick Behrendt, Martina Guthoff, et al.. (2023). Oral Zinc Supplementation in Chronically HEV-Infected Patients Not Responding to Ribavirin Monotherapy. Hepatitis Monthly. 23(1). 1 indexed citations
8.
Bläker, Hendrik, et al.. (2023). Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis. Zeitschrift für Gastroenterologie. 61(11). 1500–1503. 1 indexed citations
9.
Maier, Melanie, Janett Fischer, Mario Hönemann, et al.. (2022). Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection. Pathogens. 11(5). 517–517. 19 indexed citations
10.
Blank, Valentin, Johannes Wiegand, Volker Keim, & Thomas Karlas. (2019). Evaluation of a novel tomographic ultrasound device for abdominal examinations. PLoS ONE. 14(6). e0218754–e0218754. 3 indexed citations
11.
Lübbert, Christoph, Johannes Wiegand, & Thomas Karlas. (2014). Therapy of Liver Abscesses. Visceral Medicine. 30(5). 334–341. 61 indexed citations
12.
Karlas, Thomas, Stephan Böhm, Péter Kovács, et al.. (2014). Noninvasive characterization of graft steatosis after liver transplantation. Scandinavian Journal of Gastroenterology. 50(2). 224–232. 25 indexed citations
13.
Karlas, Thomas, David Petroff, Nikita Garnov, et al.. (2014). Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy. PLoS ONE. 9(3). e91987–e91987. 124 indexed citations
14.
Maier, Melanie, Uwe G. Liebert, Christian Wittekind, et al.. (2013). Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B. PLoS ONE. 8(6). e67481–e67481. 10 indexed citations
15.
Karlas, Thomas, Jonas Rosendahl, Christoph Benckert, et al.. (2011). Acoustic radiation force impulse (ARFI) elastography in acute liver failure: necrosis mimics cirrhosis. Zeitschrift für Gastroenterologie. 49(4). 443–448. 32 indexed citations
16.
Tillmann, Hans L., Amber Thompson, Keyur Patel, et al.. (2010). 125 IL28B POLYMORPHISM IS ASSOCIATED WITH JAUNDICE DURING ACUTE HCV INFECTION AND IS A STRONG PREDICTOR FOR SPONTANEOUS CLEARANCE IN THE PROSPECTIVE GERMAN ANTI-D COHORT. Journal of Hepatology. 52. S56–S56. 4 indexed citations
17.
Kaiser, Thorsten, Uwe G. Liebert, Alexander Leichtle, et al.. (2008). Prevalence, Aetiology and Associated Co-Morbidities of Elevated Aminotransferases in a German Cohort of Orthopaedic Surgery Patients. Zeitschrift für Gastroenterologie. 46(5). 415–420. 12 indexed citations
18.
Wiegand, Johannes, Markus Cornberg, Nuray Aslan, et al.. (2007). Fate and Function of Hepatitis-C-Virus-Specific T-Cells during Peginterferon-α2b therapy for Acute Hepatitis C. Antiviral Therapy. 12(3). 303–316. 19 indexed citations
19.
Potthoff, Andrej, et al.. (2005). Superiority of standard interferon-a2b compared to pegylated interferon-a2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?. Clinical Nephrology. 63(3). 232–235. 13 indexed citations
20.
Wedemeyer, Heiner, Johannes Wiegand, Markus Cornberg, & Michael P. Manns. (2002). Polyethylene glycol–interferon: Current status in hepatitis C virus therapy. Journal of Gastroenterology and Hepatology. 17(s3). S344–50. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoav Lurie Breakdown of academic impact, for papers by Mark Wright Breakdown of academic impact, for papers by John Koskinas Breakdown of academic impact, for papers by Norio Horiike Breakdown of academic impact, for papers by Massimo Colombo Breakdown of academic impact, for papers by Chung‐Feng Huang Breakdown of academic impact, for papers by M.P. Manns Breakdown of academic impact, for papers by Masaru Enomoto Breakdown of academic impact, for papers by Ramazan Idılman Breakdown of academic impact, for papers by Holger Hinrichsen
Rankless by CCL
2026